Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania (Q43949629)

28 November 2017

Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania (English)

1 reference

28 November 2017

0 references

Plasmodium falciparum

0 references

pyrimethamine

0 references

author name string

Michele D Hastings

1

1 reference

28 November 2017

Sarah J Bates

2

1 reference

28 November 2017

Eric A Blackstone

3

1 reference

28 November 2017

Stephanie M Monks

4

1 reference

28 November 2017

Theonest K Mutabingwa

5

1 reference

28 November 2017

Carol Hopkins Sibley

6

1 reference

28 November 2017

1 November 2002

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

28 November 2017

1 reference

28 November 2017

96

1 reference

28 November 2017

6

1 reference

28 November 2017

674-676

1 reference

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Antimalarial drug resistance: the pace quickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

In vitro recombination during PCR of Plasmodium falciparum DNA: a potential pitfall in molecular population genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2802%2990349-4

10.1016/S0035-9203(02)90349-4

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference